The Globe and Mail reports in its Wednesday, April 30, edition that RBC Capital analyst Drew McReynolds has reaffirmed his "sector perform" recommendation for Thomson Reuters. The Globe's David Leeder writes that Mr. McReynolds boosted his share target to $182 from $177 (all figures U.S.). Analysts on average target the shares at $177.56. Mr. McReynolds says in a note: "At current valuation, we believe the bar to deliver mid-to-high single digit consolidated organic revenue growth has risen with the organic revenue growth trajectory through 2025–2026 now taking centre stage. ... We continue to view Thomson Reuters as a core holding within our coverage underpinned by accelerating organic revenue growth, highly resilient earnings, a strong balance sheet and healthy FCF generation and capital returns. We believe current valuation levels are fundamentally justified provided that: (I) management now meets or exceeds a 7– to 8-per-cent organic revenue growth trajectory by 2026 without meaningful changes to the company's current margin, capex and FCF conversion profile; and (ii) solid execution on the GenAI playbook continues with little change to the current GenAI narrative including perceived opportunities and risks."